CMS REMINDER: Billing for Stem Cell Transplants
March 2018 ~
CMS has issued a reminder to providers regarding over-payment and correct billing for many stem cell transplants incorrectly.
This reminder, published in the March 22nd issue of MLN Connects, is as follows:
Billing for Stem Cell Transplants – Reminder
In a February 2016 report, the Office of the Inspector General (OIG) determined that Medicare paid for many stem cell transplants incorrectly. The main finding was that providers billed these procedures as inpatient when they should have been submitted as outpatient services.
CMS suggest providers and billing professionals utilize the following resources to avoid over-payment recoveries and ensure correct billing:
- Medicare Did Not Pay Selected Inpatient Claims for Bone Marrow and Stem Cell Transplant Procedures in Accordance with Medicare Requirements OIG Report
- OIG Report: Stem Cell Transplantation MLN Matters® Article
- CMS Transmittal 1805
Source(s): MLN Connects for March 22, 2018;